Cellular effects of reversed amidines on Trypanosoma cruzi.
Aromatic diamidines represent a class of DNA minor groove-binding ligands that exhibit high levels of antiparasitic activity. Since the chemotherapy for Chagas' disease is still an unsolved problem and previous reports on diamidines and related analogues show that they have high levels of activity against Trypanosoma cruzi infection both in vitro and in vivo, our present aim was to evaluate the cellular effects in vitro of three reversed amidines (DB889, DB702, and DB786) and one diguanidine (DB711) against both amastigotes and bloodstream trypomastigotes of T. cruzi, the etiological agent of Chagas' disease. Our data show that the reversed amidines have higher levels of activity than the diguanidine, with the order of trypanocidal activities being as follows: DB889 > DB702 > DB786 > DB711. Transmission electron microscopy analysis showed that the reversed amidines induced many alterations in the nuclear morphology, swelling of the endoplasmic reticulum and Golgi structures, and consistent damage in the mitochondria and kinetoplasts of the parasites. Interestingly, in trypomastigotes treated with the reversed amidine DB889, multiple axoneme structures (flagellar microtubules) were noted. Flow cytometry analysis confirmed that the treated parasites presented an important loss of the mitochondrial membrane potential, as revealed by a decrease in rhodamine 123 fluorescence. Our results show that the reversed amidines have promising activities against the relevant mammalian forms of T. cruzi and display high trypanocidal effects at very low doses. This is especially the case for DB889, which merits further in vivo evaluation.
Silva
C F
CF
Laboratory de Biologia Celular, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil 4365, 21040-900 Rio de Janeiro, RJ, Brazil.
Meuser
M B
MB
De Souza
E M
EM
Meirelles
M N L
MN
Stephens
C E
CE
Som
P
P
Boykin
D W
DW
Soeiro
M N C
MN
D000578:Amidines / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D002522:Chlorocebus aethiops; D004305:Dose-Response Relationship, Drug; D005663:Furans / Q000494:pharmacology; D019791:Guanidine / Q000031:analogs & derivatives / Q000494:pharmacology; D020128:Inhibitory Concentration 50; D046529:Microscopy, Electron, Transmission; D015394:Molecular Structure; D021261:Parasitic Sensitivity Tests; D013329:Structure-Activity Relationship; D014344:Trypanocidal Agents / Q000737:chemistry / Q000494:pharmacology*; D014349:Trypanosoma cruzi / Q000187:drug effects* / Q000648:ultrastructure*; D014709:Vero Cells
D000578:Amidines; D005663:Furans; D014344:Trypanocidal Agents; C520808:diguanidine; D019791:Guanidine
J Antimicrob Chemother. 2006 Sep;58(3):610-4
16854954
Z Parasitenkd. 1982;68(1):7-14
6753392
Expert Opin Investig Drugs. 2005 Aug;14(8):957-72
16050790
Biol Cell. 1988;64(2):137-43
3067795
Ann Trop Med Parasitol. 1982 Feb;76(1):37-43
7082077
Ann Trop Med Parasitol. 1977 Jun;71(2):157-66
869606
Parasite. 2000 Jun;7(2):103-8
10887656
J Med Chem. 2001 May 24;44(11):1741-8
11356109
Trends Parasitol. 2003 Nov;19(11):495-501
14580960
J Antimicrob Chemother. 2004 Oct;54(4):704-10
15329361
Curr Opin Investig Drugs. 2006 Feb;7(2):147-57
16499285
Parasitol Today. 2000 Jan;16(1):1-3
10637575
Biochem Pharmacol. 2004 Aug 15;68(4):593-600
15276066
Bioorg Med Chem Lett. 2003 Jun 16;13(12):2065-9
12781196
Biochem Pharmacol. 2007 Jun 15;73(12):1939-46
17462605
Parasitol Res. 1989;75(4):257-63
2649878
Kinetoplastid Biol Dis. 2002 May 31;1(1):3
12234386
Parasitology. 2006 Jul;133(Pt 1):75-9
16563202
FEMS Microbiol Lett. 2006 Mar;256(2):209-16
16499608
Antimicrob Agents Chemother. 2006 Jun;50(6):2185-91
16723581
Exp Parasitol. 2006 Jan;112(1):21-30
16293247
Lancet. 2005 Aug 6-12;366(9484):486-7
16084257
Parasite. 1997 Jun;4(2):133-9
9296058
Mol Pharmacol. 2001 Mar;59(3):586-92
11179454
Acta Trop. 1998 Jun 15;70(1):43-61
9707364
Curr Med Chem Anticancer Agents. 2005 Jul;5(4):389-408
16101490
Mem Inst Oswaldo Cruz. 2002 Jan;97(1):3-24
11992141
Parasitol Res. 2006 Dec;100(1):187-90
16855821